397 related articles for article (PubMed ID: 37534058)
1. Combined Donepezil with Astaxanthin via Nanostructured Lipid Carriers Effective Delivery to Brain for Alzheimer's Disease in Rat Model.
Shehata MK; Ismail AA; Kamel MA
Int J Nanomedicine; 2023; 18():4193-4227. PubMed ID: 37534058
[TBL] [Abstract][Full Text] [Related]
2. Nose to Brain Delivery of Astaxanthin-Loaded Nanostructured Lipid Carriers in Rat Model of Alzheimer's Disease: Preparation, in vitro and in vivo Evaluation.
Shehata MK; Ismail AA; Kamel MA
Int J Nanomedicine; 2023; 18():1631-1658. PubMed ID: 37020692
[TBL] [Abstract][Full Text] [Related]
3. Design and development of donepezil hydrochloride loaded nanostructured lipid carriers for efficient management of Alzheimer's disease.
Tekade AR; Suryavanshi MR; Shewale AB; Patil VS
Drug Dev Ind Pharm; 2023 Sep; 49(9):590-600. PubMed ID: 37733474
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective Potential of Curcumin-Loaded Nanostructured Lipid Carrier in an Animal Model of Alzheimer's Disease: Behavioral and Biochemical Evidence.
Sadegh Malvajerd S; Izadi Z; Azadi A; Kurd M; Derakhshankhah H; Sharifzadeh M; Akbari Javar H; Hamidi M
J Alzheimers Dis; 2019; 69(3):671-686. PubMed ID: 31156160
[TBL] [Abstract][Full Text] [Related]
5. Quercetin-Loaded Nanostructured Lipid Carrier In Situ Gel for Brain Targeting Through Intranasal Route: Formulation, In Vivo Pharmacokinetic and Pharmacodynamic Studies.
Sonawane D; Pokharkar V
AAPS PharmSciTech; 2024 Feb; 25(2):30. PubMed ID: 38316672
[TBL] [Abstract][Full Text] [Related]
6. Chitosan-coated nanostructured lipid carriers for effective brain delivery of Tanshinone IIA in Parkinson's disease: interplay between nuclear factor-kappa β and cathepsin B.
Hassan DM; El-Kamel AH; Allam EA; Bakr BA; Ashour AA
Drug Deliv Transl Res; 2024 Feb; 14(2):400-417. PubMed ID: 37598133
[TBL] [Abstract][Full Text] [Related]
7. Silibinin-loaded nanostructured lipid carriers (NLCs) ameliorated cognitive deficits and oxidative damages in aluminum chloride-induced neurotoxicity in male mice.
Makhdoomi S; Mahboobian MM; Haddadi R; Komaki A; Mohammadi M
Toxicology; 2022 Jul; 477():153260. PubMed ID: 35850386
[TBL] [Abstract][Full Text] [Related]
8. Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy.
Alam T; Pandit J; Vohora D; Aqil M; Ali A; Sultana Y
Expert Opin Drug Deliv; 2015 Feb; 12(2):181-94. PubMed ID: 25164097
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of nanostructured lipid carrier-based gels for the transdermal delivery of donepezil.
Mendes IT; Ruela ALM; Carvalho FC; Freitas JTJ; Bonfilio R; Pereira GR
Colloids Surf B Biointerfaces; 2019 May; 177():274-281. PubMed ID: 30763792
[TBL] [Abstract][Full Text] [Related]
10. Preparation of tripterine nanostructured lipid carriers and their absorption in rat intestine.
Zhou L; Chen Y; Zhang Z; He J; Du M; Wu Q
Pharmazie; 2012 Apr; 67(4):304-10. PubMed ID: 22570936
[TBL] [Abstract][Full Text] [Related]
11. Formulation and optimization of intranasal nanolipid carriers of pioglitazone for the repurposing in Alzheimer's disease using Box-Behnken design.
Jojo GM; Kuppusamy G; De A; Karri VVSNR
Drug Dev Ind Pharm; 2019 Jul; 45(7):1061-1072. PubMed ID: 30922126
[TBL] [Abstract][Full Text] [Related]
12. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.
Wang W; Chen L; Huang X; Shao A
AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090
[TBL] [Abstract][Full Text] [Related]
13. Formulation of intranasal surface engineered nanostructured lipid carriers of rotigotine: Full factorial design optimization, in vitro characterization, and pharmacokinetic evaluation.
Zafar A; Awad Alsaidan O; Alruwaili NK; Sarim Imam S; Yasir M; Saad Alharbi K; Singh L; Muqtader Ahmed M
Int J Pharm; 2022 Nov; 627():122232. PubMed ID: 36155794
[TBL] [Abstract][Full Text] [Related]
14. Surface engineered nanostructured lipid carriers for efficient nose to brain delivery of ondansetron HCl using Delonix regia gum as a natural mucoadhesive polymer.
Devkar TB; Tekade AR; Khandelwal KR
Colloids Surf B Biointerfaces; 2014 Oct; 122():143-150. PubMed ID: 25033434
[TBL] [Abstract][Full Text] [Related]
15. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery.
Kawadkar J; Pathak A; Kishore R; Chauhan MK
Drug Dev Ind Pharm; 2013 Apr; 39(4):569-78. PubMed ID: 22639934
[TBL] [Abstract][Full Text] [Related]
16. In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers.
Rashidzadeh H; Salimi M; Sadighian S; Rostamizadeh K; Ramazani A
Curr Drug Deliv; 2019; 16(10):923-930. PubMed ID: 31663477
[TBL] [Abstract][Full Text] [Related]
17. Pentoxifylline as Add-On Treatment to Donepezil in Copper Sulphate-Induced Alzheimer's Disease-Like Neurodegeneration in Rats.
Elseweidy MM; Mahrous M; Ali SI; Shaheen MA; Younis NN
Neurotox Res; 2023 Dec; 41(6):546-558. PubMed ID: 37821782
[TBL] [Abstract][Full Text] [Related]
18. Transferrin decorated-nanostructured lipid carriers (NLCs) are a promising delivery system for rapamycin in Alzheimer's disease: An in vivo study.
Khonsari F; Heydari M; Sharifzadeh M; Valizadeh H; Dinarvand R; Atyabi F
Biomater Adv; 2022 Jun; 137():212827. PubMed ID: 35929260
[TBL] [Abstract][Full Text] [Related]
19. Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route.
Gabal YM; Kamel AO; Sammour OA; Elshafeey AH
Int J Pharm; 2014 Oct; 473(1-2):442-57. PubMed ID: 25062866
[TBL] [Abstract][Full Text] [Related]
20. Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides.
Yang G; Wu F; Chen M; Jin J; Wang R; Yuan Y
Int J Nanomedicine; 2019; 14():2267-2280. PubMed ID: 31015758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]